• Je něco špatně v tomto záznamu ?

Genetic Markers at ANRIL, FTO and 2q36.3 Locus in Czech Patients Undergoing Coronary Artery Bypass Graft Surgery

P. Kacer, J. Pirk, V. Lanska, J. A. Hubacek, V. Adamek, T. Cervinkova, J. Belohoubek, O. Auzky, V. Adamkova

. 2020 ; 66 (4) : 148-153.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21014133

Coronary artery bypass graft (CABG) surgery is one of the most commonly performed operations worldwide. We compared genotype frequencies of three major cardiovascular disease (CVD)-associated genetic markers (ANRIL, FTO and 2q36.3 locus) between 753 patients who underwent CABG at the Institute for Clinical and Experimental Medicine (Prague, Czech Republic) and 2,559 controls from the Czech post-MONICA study. Subjects with at least one major A allele in the rs10757274 polymorphism (ANRIL) were more prevalent in patients after CABG than in the controls (81.7 % vs 72.7 %; OR [95 % CI] 1.67 [1.35-2.05]; P < 0.0001). In contrast, variants within the FTO gene (OR 0.87; 95 % CI, 0.70-1. 09 in a TT vs. GG comparison, P = 0.24) and 2q36.3 locus (OR 1.16; 95% CI, 0.98-1.37 in a +A vs. CC comparison, P = 0.08) were not significantly associated with CVD in our study. Variants were not associated with anthropometric, biochemical, or clinical characteristics within the patient group. Our study suggests that patients with CABG are more commonly carriers of some but not all CVD-associated alleles.

Bibliografie atd.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc21014133
003      
CZ-PrNML
005      
20210528134155.0
007      
ta
008      
210504s2020 xr f 000 0|eng||
009      
AR
035    __
$a (PubMed)33745262
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Kačer, Petr, $d 1969 září 21.- $7 xx0230547 $u Department of Cardiac Surgery, Královské Vinohrady University Hospital in Prague, Third Faculty of Medicine, Charles University, Prague, Czech Republic; Cardiocentre; Institute for Clinical and Experimental Medicine, Prague, Czech Republic
245    10
$a Genetic Markers at ANRIL, FTO and 2q36.3 Locus in Czech Patients Undergoing Coronary Artery Bypass Graft Surgery / $c P. Kacer, J. Pirk, V. Lanska, J. A. Hubacek, V. Adamek, T. Cervinkova, J. Belohoubek, O. Auzky, V. Adamkova
504    __
$a Literatura
520    9_
$a Coronary artery bypass graft (CABG) surgery is one of the most commonly performed operations worldwide. We compared genotype frequencies of three major cardiovascular disease (CVD)-associated genetic markers (ANRIL, FTO and 2q36.3 locus) between 753 patients who underwent CABG at the Institute for Clinical and Experimental Medicine (Prague, Czech Republic) and 2,559 controls from the Czech post-MONICA study. Subjects with at least one major A allele in the rs10757274 polymorphism (ANRIL) were more prevalent in patients after CABG than in the controls (81.7 % vs 72.7 %; OR [95 % CI] 1.67 [1.35-2.05]; P < 0.0001). In contrast, variants within the FTO gene (OR 0.87; 95 % CI, 0.70-1. 09 in a TT vs. GG comparison, P = 0.24) and 2q36.3 locus (OR 1.16; 95% CI, 0.98-1.37 in a +A vs. CC comparison, P = 0.08) were not significantly associated with CVD in our study. Variants were not associated with anthropometric, biochemical, or clinical characteristics within the patient group. Our study suggests that patients with CABG are more commonly carriers of some but not all CVD-associated alleles.
650    _2
$a gen pro FTO $x genetika $7 D000071516
650    12
$a koronární bypass $7 D001026
650    12
$a nemoci koronárních tepen $x genetika $7 D003324
650    12
$a genetické markery $7 D005819
650    _2
$a genotyp $7 D005838
650    _2
$a lidé $7 D006801
650    _2
$a polymorfismus genetický $7 D011110
650    _2
$a RNA dlouhá nekódující $x genetika $7 D062085
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
700    1_
$a Pirk, Jan, $d 1948- $7 nlk19990073700 $u Cardiocentre; Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Lánská, Věra $7 xx0062305 $u Medical Statistics Unit; Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Hubáček, Jaroslav, $d 1966- $7 nlk20050169367 $u Centre for Experimental Medicine; Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Adámek, Václav $7 jo2015866162 $u Department of Preventive Cardiology; Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Červinková, Tereza $7 _AN096575 $u Department of Preventive Cardiology; Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Bělohoubek, Jiří $7 xx0194663 $u Department of Preventive Cardiology; Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Auzký, Ondřej $7 xx0095368 $u Department of Preventive Cardiology; Institute for Clinical and Experimental Medicine, Prague, Czech Republic
700    1_
$a Adámková, Věra, $d 1954- $7 jx20050329003 $u Department of Preventive Cardiology; Institute for Clinical and Experimental Medicine, Prague, Czech Republic
773    0_
$w MED00011004 $t Folia biologica $x 0015-5500 $g Roč. 66, č. 4 (2020), s. 148-153
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33745262 $y Pubmed
856    41
$u https://fb.cuni.cz/file/5934/fb2020a0020.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 970 $c 89 $y p $z 0
990    __
$a 20210504 $b ABA008
991    __
$a 20210521122149 $b ABA008
999    __
$a ok $b bmc $g 1657546 $s 1134521
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 66 $c 4 $d 148-153 $i 0015-5500 $m Folia biologica (Praha) $n Folia biol. (Praha) $x MED00011004
LZP    __
$b NLK118 $a Pubmed-20210504

Najít záznam

Citační ukazatele

Možnosti archivace